GenomeWeb January 12, 2018
Justin Petrone

American customers’ interest in their genetic ancestry continues to be the primary driver of the consumer genomics market and shows no signs of diminishing.

Ancestry, for example, disclosed in November that it sold 1.7 million kits during Black Friday/Cyber Monday for its AncestryDNA service, roughly tripling the number of kits it sold over the same weekend the previous year.

Ken Chahine, executive vice president and general manager at AncestryDNA, said the Provo, Utah-based firm now has more than 6 million people in its database, and aims to deliver “deeper insights” to users in 2018.

At Insitome, an Austin, Texas-based company that develops genomic analysis applications that sell on the Helix marketplace, the introduction last month of an offering for Regional...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Precision Medicine
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article